Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
170.50
-0.50 (-0.29%)
May 21, 2025, 1:30 PM CST
TPEX:6712 Revenue
Ever Supreme Bio Technology had revenue of 177.92M TWD in the quarter ending March 31, 2025, with 8.93% growth. This brings the company's revenue in the last twelve months to 948.40M, up 17.84% year-over-year. In the year 2024, Ever Supreme Bio Technology had annual revenue of 933.81M with 23.13% growth.
Revenue (ttm)
948.40M
Revenue Growth
+17.84%
P/S Ratio
14.32
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.58B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 933.81M | 175.42M | 23.13% |
Dec 31, 2023 | 758.39M | 130.88M | 20.86% |
Dec 31, 2022 | 627.51M | 188.67M | 42.99% |
Dec 31, 2021 | 438.84M | 368.24M | 521.61% |
Dec 31, 2020 | 70.60M | 59.78M | 552.53% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Oneness Biotech | 117.33M |
Center Laboratories | 1.63B |
Pegavision | 6.69B |